A multicentre, open label, comparative study to evaluate the efficacy, safety and tolerability of rosiglitazone + metformin vs glibencamide + metformin (fixed combination) in type 2 diabetic subjects fairly controlled on up to half maximal dose of monotherapy drugs and requiring tighter metaboli ..., Trial ID 49653%2F154 | GSK